Current Medicinal Chemistry - Anti-Cancer Agents
Title: Preface [Hot Topic: Anticancer Agents: To Kill in a Good Cause (Guest Editor : Eric Solary)].
Volume: 3 Issue: 4
Author(s): Eric Solary
Affiliation:
Export Options
About this article
Cite this article as:
Solary Eric, Preface [Hot Topic: Anticancer Agents: To Kill in a Good Cause (Guest Editor : Eric Solary)]., Current Medicinal Chemistry - Anti-Cancer Agents 2003; 3 (4) . https://dx.doi.org/10.2174/1568011033482387
DOI https://dx.doi.org/10.2174/1568011033482387 |
Print ISSN 1568-0118 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5968 |
7
Related Articles
-
Editorial [Hot Topic: Clinical Trials in ANCA Associated Vasculitis (Guest Editor: Chetan Mukhtyar)]
Current Immunology Reviews (Discontinued) A Review on Advances in Organoborane-Chemistry: Versatile Tool in Asymmetric Synthesis
Current Organic Synthesis Strategies to Improve the Functions and Redox State of the Immune System in Aged Subjects
Current Pharmaceutical Design The AmpliChip: A Review of its Analytic and Clinical Validity and Clinical Utility
Current Drug Safety Pharmacokinetic Evaluation of Callistemon viminalis Derived Natural Compounds as Targeted Inhibitors Against δ -Opioid Receptor and Farnesyl Transferase
Letters in Drug Design & Discovery Efficient Heterogeneously Palladium-Catalysed Synthesis of Stilbenes and Bibenzyls
Letters in Organic Chemistry Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Current Topics in Medicinal Chemistry Metabolite Quantification in Tumours by Magnetic Resonance Spectroscopy: Objectives, Results and Perspectives
Current Medical Imaging Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulomatosis with Polyangiitis
Current Genomics The Polyhedric Abl Kinases and their Pharmacologic Inhibitors
Current Enzyme Inhibition Meet Our Editorial Board Member
Current Cancer Drug Targets Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Recent Patents on Anti-Cancer Drug Discovery Evaluation of the Stability of Resveratrol Pluronic<sup>®</sup> Micelles Prepared by Solvent Casting and Simple Equilibrium Methods
Pharmaceutical Nanotechnology Photoactivatable Platinum Complexes
Anti-Cancer Agents in Medicinal Chemistry Compounds Derived from Epigallocatechin-3-Gallate (EGCG) as a Novel Approach to the Prevention of Viral Infections
Inflammation & Allergy - Drug Targets (Discontinued) Editorial (Thematic Issue: Special Thematic Issue: Crossreactivity in Cancer and Autoimmunity)
Anti-Cancer Agents in Medicinal Chemistry Antimicrobial, Anticancer Drug Carrying Properties of Biopolymers-based Nanocomposites- A Mini Review
Current Pharmaceutical Design New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer
Current Pharmaceutical Design Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Transfer of DNA Encoding Adenoviral E1A
Recent Patents on Anti-Cancer Drug Discovery